Prediabetic State Clinical Trials

15 recruiting

Prediabetic State Trials at a Glance

16 actively recruiting trials for prediabetic state are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in New York, Salt Lake City, and Durham. Lead sponsors running prediabetic state studies include Columbia University, Cedars-Sinai Medical Center, and Beneficência Portuguesa de São Paulo.

Browse prediabetic state trials by phase

Treatments under study

About Prediabetic State Clinical Trials

Looking for clinical trials for Prediabetic State? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Prediabetic State trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Prediabetic State clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Exercise Training and Fat Metabolism in Postmenopausal Women

ObesityPostmenopausal SymptomsPrediabetic State
Florida State University120 enrolled1 locationNCT05351476
Recruiting
Phase 1

Effect of Insulin Lowering on Lipogenesis

ObesityInsulin ResistanceNon-Alcoholic Fatty Liver Disease+2 more
Columbia University25 enrolled1 locationNCT07403604
Recruiting
Phase 1

Human Models of Selective Insulin Resistance: Alpelisib, Part I

Insulin ResistanceNon-Alcoholic Fatty Liver DiseaseOverweight and Obesity+1 more
Columbia University32 enrolled1 locationNCT06354088
Recruiting
Not Applicable

Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center

Prediabetic State
Cedars-Sinai Medical Center20 enrolled1 locationNCT06897982
Recruiting
Phase 4

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

AtherosclerosisMetforminPrediabetic State
VA Office of Research and Development7,410 enrolled40 locationsNCT02915198
Recruiting
Not Applicable

Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk

Diabetes Mellitus, Type 2Prediabetic StateSleep Initiation and Maintenance Disorders
Kaiser Permanente300 enrolled1 locationNCT06067139
Recruiting
Not Applicable

Role of Aging and Individual Variation in Exercise Training Responsiveness

ObesityInsulin ResistanceCardiovascular Diseases+1 more
Duke University26 enrolled1 locationNCT06471569
Recruiting
Not Applicable

Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control

ObesityDiabetes Mellitus, Type 2Hyperglycemia+1 more
University of Toronto120 enrolled1 locationNCT06118931
Recruiting
Not Applicable

Heat and Exercise in Aging as Therapy (HEAT)

Prediabetic State
Texas Tech University54 enrolled1 locationNCT06580964
Recruiting
Not Applicable

Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors

Prediabetic State
Université de Sherbrooke48 enrolled1 locationNCT05123963
Recruiting
Not Applicable

PreventT2 Together: Examining the Efficacy of Couple-based Lifestyle Intervention to Prevent Type 2 Diabetes

ObesityPhysical ActivityPrediabetic State+3 more
University of Utah324 enrolled1 locationNCT06690788
Recruiting
Phase 4

Effect of Zinc on Glucose Homeostasis

HyperglycemiaPrediabetic State
University of Maryland, Baltimore200 enrolled1 locationNCT05835037
Recruiting
Phase 4

The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

Prediabetic State (IGT)
Beijing Tsinghua Chang Gung Hospital398 enrolled3 locationsNCT06750783
Recruiting
Not Applicable

Effectiveness of the Brazilian Diabetes Prevention Program

Prediabetic State
Beneficência Portuguesa de São Paulo1,590 enrolled2 locationsNCT06426277
Recruiting
Not Applicable

Antidiabetic Effect of Olive Pomace Oil

Diabetes MellitusDiabetesType 2 Diabetes Mellitus+2 more
Instituto de Ciencia y Tecnología de Alimentos y Nutrición50 enrolled1 locationNCT06723886
Recruiting
Not Applicable

Plant Sterols on Cardiovascular Markers, Microbiota and Sterol Metabolism (Cardiofoodsterol)

Cardiovascular DiseasesOverweight and ObesityPrediabetic State+1 more
University of Valencia42 enrolled1 locationNCT06481020